The current valuation score of Ligand Pharmaceuticals Inc is 6.86, ranking 147 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is 35.82, which is 143.92% below the recent high of 87.38 and 1647.78% above the recent low of -554.46.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.